Project Grant R03AG089004
Award Date
9/15/24
Completion Date
8/31/26
Dollars Obligated
$322K
Federal Agency
National Institute on Aging
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Rochester provides $308,000 in funding to develop and pilot test a shared decision-making (SDM) tool for surgeons to use when discussing major colorectal surgery with frail older adult patients. The goal is to improve communication and decision-making in this vulnerable patient population that experiences higher complication rates and impacts to quality of life from such...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a pilot study to evaluate the feasibility of using a "patient priorities care framework" to facilitate individualized breast cancer survivorship care for older women with multiple chronic conditions. The $624,000 award, effective from September 27, 2024 to August 31, 2026, will support the University of Texas Health Science Center at Houston in carrying out this quasi-experimental...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $811,443.00 to Beth Israel Deaconess Medical Center, Inc. to conduct a cluster randomized trial evaluating the impact of a shared decision-making training program for breast surgeons and a decision aid for women aged 70+ newly diagnosed with early-stage, low-risk breast cancer. The goal is to assess whether this intervention reduces the use of low-value treatments, such as mastectomy, sentinel...
The National Institute on Aging (NIA), under the Federal Aging Research Grant Program (CFDA 93.866), awarded a $242,956 Project Grant to the University of Colorado-Denver to support the development and evaluation of a decision aid to improve shared decision-making for older adults with Parkinson's disease and mild cognitive impairment (MCI) considering deep brain stimulation (DBS) surgery. The key objectives of this 5-year project are to: 1) adapt and refine an existing DBS decision aid to...
The federal Project Grant award R01AG089237, funded by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to determine the effectiveness of a shared decision-making (SDM) toolkit in decreasing surveillance mammography use among breast cancer survivors aged 80 and older. The total award amount is $943,540.00 over the project period from Sep 15, 2024 to Aug 31, 2029. The award recipient is the Dana-Farber Cancer Institute, Inc. (DFCI), a non-profit hospital and cancer...
This federal Project Grant award, funded by the National Institute on Aging under CFDA program 93.866 Aging Research, aims to develop and pilot a patient decision aid to support shared decision-making between clinicians, patients, and caregivers regarding pharmacologic therapies for dementia. The $234,000 grant will be awarded to the University of Colorado-Denver and has a project period from September 2024 to August 2026. The key products and services to be delivered through this grant include:...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $799,107 Project Grant to the Dana-Farber Cancer Institute, Inc. in Boston, MA to conduct research on using genomic biomarkers and decision analysis frameworks to guide treatment decisions for stage III melanoma patients. The grant will fund a collaborative project involving researchers from Dana-Farber and Brigham & Women's Hospital to develop methods for translating genomic and...
This federal Project Grant award from the National Cancer Institute (NCI), under CFDA Program 93.393 "Cancer Cause and Prevention Research", provides $678,204 to the University of Rochester to support a research project titled "A Decisional Intervention for Older Adults with Acute Myeloid Leukemia and Their Caregivers". The project aims to investigate therapeutic advances that have allowed more adults aged 60 years with acute myeloid leukemia (AML) to receive...
The National Cancer Institute (NCI) awarded a $395,509 Project Grant under CFDA 93.396 "Cancer Biology Research" to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research on targeting the SKP2 axis for anti-melanoma therapy. The research aims to: 1) investigate how the dysregulated RNF12-SKP2 E3 ligase cascade promotes melanoma tumorigenesis, and 2) examine how SKP2-mediated degradation of the tumor suppressor HHIP plays a role in melanoma development. The project...
The National Institute on Aging (NIA) awarded a $702,963 Project Grant (CFDA 93.866 - Aging Research) to Duke University to conduct a multi-center randomized controlled trial (RCT) of the ICUConnect 2 mobile app-based primary palliative care intervention. The goal is to improve palliative care quality and other person-centered outcomes among racially/ethnically diverse older adults receiving intensive care. The project will test the intervention against usual care across 4 sites (Duke, Medical...